Meningitis Vaccine Expected in a Year

by Tanya Thomas on  December 25, 2010 at 7:29 AM Research News   - G J E 4
A new vaccine for meningitis B, the strain against which there is currently no defense, is currently being tested.

According to experts, it will dramatically reduce the risk of children dying from the disease, reports the Daily Mail.
 Meningitis Vaccine Expected in a Year
Meningitis Vaccine Expected in a Year

Meningococcal B is the most common form of bacterial meningitis in UK and one of the most deadly, in some cases killing in a few hours.

Although vaccination programmes have been successfully introduced to combat pneumococcal meningitis and the strains C and Hib, no B vaccine currently exists in this country.

Bexsero is the first vaccine providing broad protection against 800 deadly, disease-circulating meningococcal B strains and could be available as soon as next year.

Results from 7,500 children, adolescents and adults taking part in trials show they produced antibodies against 77 per cent of these strains.

Teams from the Health Protection Agency have helped to test the jab, developed by Novartis.

It is likely to be approved in the next few months, paving the way for inclusion in the childhood immunisation programme.

The vaccine was developed using so-called 'reverse vaccinology', decoding the genome sequence of meningitis B and selecting proteins most likely to be broadly-effective vaccine candidates.

Source: ANI

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like